Slingshot members are tracking this event:

Top-Line data from AstraZeneca's (AZN) Phase 3 ALPS of Roxadustat for Anemia Due to Chronic Renal Failure expected Q2 2018

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
AZN Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 20, 2018
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Roxadustat